Mai Sugahara

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Paralytic Ileus during Treatment of Pulmonary and Renal Tuberculosis in a Non-Human Immunodeficiency Virus Patient: An Unusual Presentation of Tuberculosis-immune Reconstitution Inflammatory Syndrome.

Paralytic Ileus during Treatment of Pulmonary and Renal Tuberculosis in a Non-Human Immunodeficiency Virus Patient: An Unusual Presentation of Tuberculosis-immune Reconstitution Inflammatory Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: January 15, 2023

Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors.

Journal: Pharmacology & therapeutics

Published: May 26, 2022

Activation of α7 nicotinic acetylcholine receptors attenuates monocyte-endothelial adhesion through FUT7 inhibition.

Activation of α7 nicotinic acetylcholine receptors attenuates monocyte-endothelial adhesion through FUT7 inhibition.

Journal: Biochemical and biophysical research communications

Published: December 22, 2021

Update on diagnosis, pathophysiology, and management of diabetic kidney disease.

Update on diagnosis, pathophysiology, and management of diabetic kidney disease.

Journal: Nephrology (Carlton, Vic.)

Published: January 04, 2021

Hypoxia-Inducible Factor and Oxygen Biology in the Kidney.

Hypoxia-Inducible Factor and Oxygen Biology in the Kidney.

Journal: Kidney360

Published: March 16, 2020

Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.

Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.

Journal: American journal of physiology. Renal physiology

Published: December 17, 2019

Modulating the immune system to delay the clinical onset of type 1 diabetes.

Modulating the immune system to delay the clinical onset of type 1 diabetes.

Journal: Kidney international

Published: September 08, 2019

Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.

Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 09, 2019

Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.

Inhibition of prolyl hydroxylase domain (PHD) by JTZ-951 reduces obesity-related diseases in the liver, white adipose tissue, and kidney in mice with a high-fat diet.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: August 22, 2018

ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.

ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.

Journal: Kidney international

Published: March 27, 2018

Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.

Persistent expression of neutrophil gelatinase-associated lipocalin and M2 macrophage markers and chronic fibrosis after acute kidney injury.

Journal: Physiological reports

Published: February 13, 2018

Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice.

Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice.

Journal: Kidney international

Published: September 06, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026